Lista de obras - Ewa Robak - Dominio Público Uruguay

Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features

artículo científico publicado en 2002

Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients

artículo científico publicado en 2003

Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus

artículo científico publicado en 2007

Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus

artículo científico publicado en 2006

Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients

artículo científico publicado en 2013

Current Phase II antibody-drug conjugates for the treatment of lymphoid malignancies

artículo científico publicado en 2014

Cutaneous leukocytoclastic vasculitis at diagnosis of hairy cell leukemia successfully treated with vemurafenib and rituximab

artículo científico publicado en 2021

Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity

artículo científico publicado en 2007

Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis

artículo científico publicado en 2014

Exhaled cytokines in systemic lupus erythematosus with lung involvement

artículo científico publicado en 2013

Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus

artículo científico publicado en 2014

Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients

scientific article published on 11 September 2007

Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamide

artículo científico publicado en 2002

Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab

artículo científico publicado en 2005

Methotrexate use and NAD+/NADH metabolism in psoriatic keratinocytes

artículo científico publicado en 2020

Monoclonal antibodies in the treatment of systemic lupus erythematosus

artículo científico publicado en 2009

Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma.

artículo científico publicado en 2004

New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies

artículo científico publicado el 1 de febrero de 2011

Novel systemic drugs for cutaneous T-cell lymphoma

scientific article published on January 2011

Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies

artículo científico publicado en 2006

Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms

artículo científico publicado en 2006

Pneumocystis carinii mimicking neonatal lupus erythematosus-related pneumonitis

artículo científico publicado en 2003

Primary cutaneous CD4+ small-/medium-sized T-cell lymphoproliferative disorder: A case report

artículo científico publicado en 2019

Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus

scientific article published on 01 July 2002

Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration

artículo científico publicado en 2010

Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity

artículo científico publicado en 2006

Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations

artículo científico publicado en 2010

Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders

artículo científico publicado en 2006

Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus

artículo científico publicado en 2004

Role of Toll-like receptors in etiology of selected diseases of the skin

artículo científico publicado el 3 de agosto de 2010

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis

Skin changes in hairy cell leukemia

artículo científico publicado en 2020

Skin lesions in chronic lymphocytic leukemia

artículo científico publicado en 2007

The Role of CXC Chemokines in Pulmonary Fibrosis of Systemic Lupus Erythematosus Patients

artículo científico publicado en 2015

The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosus

artículo científico publicado en 2017

The influence of clinical manifestations and treatment on satisfaction with life together with positive and negative emotions in systemic lupus erythematosus patients.

artículo científico publicado en 2011

Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders

artículo científico

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus

artículo científico publicado en 2003

Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus

artículo científico publicado en 2013

X-linked TLR7 gene polymorphisms are associated with diverse immunological conditions but not with discoid lupus erythematosus in Polish patients.

artículo científico publicado en 2018

[Acne rosacea--diagnostic challenge]

artículo científico publicado en 2006

[Connective tissue diseases during pregnancy - therapeutic aspect. Part 1: SLE, antiphosholipid syndrome]

[Connective tissue diseases during pregnancy - therapeutic aspect. Part 2: the other connective tissue diseases]

[Current views on etiopathogenesis of systemic lupus erythematosus]

scientific article published on 08 November 2011

[Diagnostic problems and evaluation of disease activity in systemic lupus erythematosus]

scientific article published on 01 January 2005

[Drug eruptions]

artículo científico publicado en 2002

[Drug-induced lupus erythematosus and systemic lupus erythematosus--differences and similarities].

artículo científico publicado en 2007

[Pro-angiogenic cytokines in systemic sclerosis]

scientific article published on 15 December 2014

[Progress and perspectives in the treatment of systemic lupus erythematosus]

artículo científico publicado en 2005

[Proinflammatory cytokines in inactive lupus erythematosus patients]

artículo científico publicado en 2005

[Quality of life in systemic lupus erythematosus patients, with a particular description of methodology]

artículo científico publicado en 2007

[Rosacea]

scientific article published on 10 September 2010

[TLR function in autoimmunological processes]

artículo científico publicado en 2009

[The role of endothelial cells in the pathogenesis of systemic lupus erythematosus]

artículo científico publicado en 2007

Lista de obras de Ewa Robak

Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features

Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients

Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus

Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus

Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients

Current Phase II antibody-drug conjugates for the treatment of lymphoid malignancies

Cutaneous leukocytoclastic vasculitis at diagnosis of hairy cell leukemia successfully treated with vemurafenib and rituximab

Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity

Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis

Exhaled cytokines in systemic lupus erythematosus with lung involvement

Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus

Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients

Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamide

Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab

Methotrexate use and NAD+/NADH metabolism in psoriatic keratinocytes

Monoclonal antibodies in the treatment of systemic lupus erythematosus

Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma.

New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies

Novel systemic drugs for cutaneous T-cell lymphoma

Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies

Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms

Pneumocystis carinii mimicking neonatal lupus erythematosus-related pneumonitis

Primary cutaneous CD4+ small-/medium-sized T-cell lymphoproliferative disorder: A case report

Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus

Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration

Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity

Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations

Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders

Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus

Role of Toll-like receptors in etiology of selected diseases of the skin

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis

Skin changes in hairy cell leukemia

Skin lesions in chronic lymphocytic leukemia

The Role of CXC Chemokines in Pulmonary Fibrosis of Systemic Lupus Erythematosus Patients

The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosus

The influence of clinical manifestations and treatment on satisfaction with life together with positive and negative emotions in systemic lupus erythematosus patients.

Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus

Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus

X-linked TLR7 gene polymorphisms are associated with diverse immunological conditions but not with discoid lupus erythematosus in Polish patients.

[Acne rosacea--diagnostic challenge]

[Connective tissue diseases during pregnancy - therapeutic aspect. Part 1: SLE, antiphosholipid syndrome]

[Connective tissue diseases during pregnancy - therapeutic aspect. Part 2: the other connective tissue diseases]

[Current views on etiopathogenesis of systemic lupus erythematosus]

[Diagnostic problems and evaluation of disease activity in systemic lupus erythematosus]

[Drug eruptions]

[Drug-induced lupus erythematosus and systemic lupus erythematosus--differences and similarities].

[Pro-angiogenic cytokines in systemic sclerosis]

[Progress and perspectives in the treatment of systemic lupus erythematosus]

[Proinflammatory cytokines in inactive lupus erythematosus patients]

[Quality of life in systemic lupus erythematosus patients, with a particular description of methodology]

[Rosacea]

[TLR function in autoimmunological processes]

[The role of endothelial cells in the pathogenesis of systemic lupus erythematosus]